A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113-Reference-Cited by-同舟云学术

A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113

Published:2016-09-01 Issue:2 Volume:123 Page:303-311
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sanborn Rachel E.¹^ORCID,Patel Jyoti D.²,Masters Gregory A.³,Jayaram Nagesh⁴,Stephens Anthony⁵,Guarino Michael³,Misleh Jamal³,Wu Jingwei⁶,Hanna Nasser⁷

Affiliation:

1. Earle A. Chiles Research Institute, Providence Cancer Center; Portland Oregon

2. Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine; Northwestern University; Chicago Illinois

3. Christiana Care Health System; Newark Delaware

4. Southeastern Medical Oncology; Jacksonville North Carolina

5. Oncology Hematology Associates Southwest Indiana; Newburgh Indiana

6. Department of Biostatistics; Indiana University; Indianapolis Indiana

7. Indiana University Simon Cancer Center; Indianapolis Indiana

Funder

AstraZeneca

Publisher

Wiley